Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
Intern Emerg Med
.
2022 Apr;17(3):929-934.
doi: 10.1007/s11739-021-02895-6.
Epub 2022 Jan 13.
Authors
C Tortajada
1
,
A Navarro
2
,
J C Andreu-Ballester
3
,
A Mayor
2
,
S Añón
2
,
J Flores
4
Affiliations
1
Infectious Disease Unit, Internal Medicine Department, Hospital Arnau de Vilanova, San Clemente 12, 46015, Valencia, Spain. ctortaja@gmail.com.
2
Internal Medicine Department, Hospital Arnau de Vilanova, San Clemente 12, 46015, Valencia, Spain.
3
Research Department, Hospital Arnau de Vilanova, San Clemente 12, 46015, Valencia, Spain.
4
Infectious Disease Unit, Internal Medicine Department, Hospital Arnau de Vilanova, San Clemente 12, 46015, Valencia, Spain.
PMID:
35023003
PMCID:
PMC8754532
DOI:
10.1007/s11739-021-02895-6
No abstract available
Keywords:
COVID-19; Cohort study; Health-related quality of life; Long-term symptoms; Post-COVID-19.
Publication types
Letter
MeSH terms
COVID-19*
Hospitalization
Humans
Patient Discharge*
Prevalence
SARS-CoV-2